Cogent Biosciences, Inc.
COGT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$81 | -$74 | -$72 | -$68 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $10 | $10 | $0 |
| Change in WC | $5 | $8 | -$5 | -$1 |
| Other Non-Cash | $11 | $0 | -$1 | $7 |
| Operating Cash Flow | -$64 | -$55 | -$67 | -$61 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$1 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$224 | -$68 | $0 | -$13 |
| Inv. Sales/Matur. | $69 | $77 | $70 | $74 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$155 | $9 | $69 | $62 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$0 | $47 | $0 | $0 |
| Stock Issued | $218 | $0 | $24 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $1 | $0 |
| Financing Cash Flow | $217 | $47 | $25 | $0 |
| Forex Effect | -$0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$2 | $2 | $28 | $1 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $128 | $126 | $98 | $97 |
| End Cash | $125 | $128 | $126 | $98 |
| Free Cash Flow | -$64 | -$55 | -$67 | -$61 |